As of January 22, 2025, Mind Medicine (MNMD) has a market cap of $0.51 billion USD. According to our data, Mind Medicine is ranked No.6076 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.51 B |
0.65%
|
Dec 31, 2024 | $0.51 B |
90.16%
|
Dec 29, 2023 | $0.27 B |
66.36%
|
Dec 30, 2022 | $0.16 B |
-89.37%
|
Dec 31, 2021 | $1.52 B |
-54.75%
|
Dec 31, 2020 | $3.35 B |
5,346.43%
|
Dec 31, 2019 | $61.60 M |
27.27%
|
Dec 31, 2018 | $48.40 M |
-85.19%
|
Dec 29, 2017 | $0.33 B |
-45.90%
|
Dec 30, 2016 | $0.60 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
COMPASS Pathways
CMPS
|
$0.34 B |
-0.000 M
|
UK
|
Atai Life Sciences
ATAI
|
$0.26 B |
0.000 M
|
Germany
|
Cybin
CYBN
|
$0.20 B |
0.000 M
|
Canada
|
Seelos Therapeutics
SEEL
|
$0.21 M |
0.023 M
|
USA
|
GH Research
GHRS
|
$0.46 B |
0.000 M
|
Ireland
|
Market Cap | = | MNMD Stock Price | * | MNMD Shares Outstanding |
= | $7.01 | * | 73.33 M | |
= | $0.51 B |